Screener
Zevra Therapeutics, Inc. ZVRA Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s gross margin?
- Zevra Therapeutics, Inc. (ZVRA) reported gross margin of 95.5% in Q2 2026.
- How has Zevra Therapeutics, Inc.'s gross margin changed year-over-year?
- Zevra Therapeutics, Inc.'s gross margin increased by 32.7% year-over-year, from 72% to 95.5%.
- What is the long-term trend for Zevra Therapeutics, Inc.'s gross margin?
- Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s gross margin has grown at a -2.3% compound annual growth rate (CAGR), from 92.8% to 84.5%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Zevra Therapeutics, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude